secwatch.observer — SEC 8-K summary
======================================

Issuer:     Allarity Therapeutics, Inc. (ALLR)
CIK:        0001860657
Form:       8-K
Filed at:   2026-09-14T16:14:05+00:00
Accession:  0001213900-26-099576
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Allarity Therapeutics' subsidiary files for SPAC IPO targeting $100M base offering
--------------------------------------------------------------------------------

- Allarity Acquisition Corp. filed Form S-1 for IPO of units; base offering $100M, up to $115M with over-allotment.
- ALLR Sponsor LLC, Allarity's wholly-owned sub, is sponsor and expected to hold ~25% of SPAC shares post-offering.
- Jesper Hoiland, Allarity board member and former Novo Nordisk EVP, to serve as Chairman of SPAC.
- SPAC to list on Nasdaq under ALLNU (units), ALLN (Class A), ALLNW (warrants); Maxim Group sole book-runner.
- Offering doesn't change Allarity's working capital runway into summer 2028.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860657/000121390026099576/0001213900-26-099576-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860657/000121390026099576/ea0305408-8k_allarity.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-099576

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer